- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06841744
Effects of Diaphragmatic Breathing on Pain, Function, Balance and Quality of Life in Pregnant Women With Low Back Pain
December 9, 2025 updated by: Kübra Akkurt, Izmir Katip Celebi University
The aim of the study was to investigate the effects of diaphragmatic breathing on pain, function, balance and quality of life in pregnant women with low back pain.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Individuals with pregnancy-related low back pain who present to the Obstetrics and Gynecology Clinic of İzmir Menemen State Hospital are identified as the study population.
Patients meeting the eligibility criteria will be included in the study.
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Çigli
-
Izmir, Çigli, Turkey (Türkiye), 35620
- Izmir Katip Celebi University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Over 18 years of age
- Pregnancy between 19-29 weeks
- Low back pain that started with pregnancy (at least 1 week; no previous history of low back pain)
- No treatment for the lumbar region or spine in the last 3 months
Exclusion Criteria:
- History of cardiovascular disease
- Multiple pregnancy
- Medical complications (e.g., bleeding, pre-eclampsia, placenta previa, etc.)
- Diagnosed cognitive disorders
- High-risk pregnancy
- History of abdominal and/or thoracic surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group
|
An information brochure on ergonomic strategies for managing low back pain during pregnancy will be provided.
|
|
Experimental: Diaphragmatic Breathing Group
|
Diaphragmatic breathing exercises will be performed twice a day, completing 3 sets of 10 repetitions, 5 days a week for 6 weeks, as instructed by the researcher physiotherapist.
An information brochure on ergonomic strategies for managing low back pain during pregnancy will be provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oswestry Disability Index
Time Frame: Baseline, 6 weeks
|
A questionnaire measuring disability associated with low back pain.
|
Baseline, 6 weeks
|
|
Numeric Pain Rating Scale
Time Frame: Baseline, 6 weeks
|
The Numeric Pain Rating Scale (NPRS) assesses pain severity using a 0-10 scale, where 0 represents "no pain" and 10 represents "the worst pain imaginable."
|
Baseline, 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timed up and go test
Time Frame: Baseline, 6 weeks
|
It measures the time required for a person to rise from a chair, walk three meters, turn, walk back to the chair, and sit down.
|
Baseline, 6 weeks
|
|
The Single Leg Stance Test
Time Frame: Baseline, 6 weeks
|
The Single Leg Stand Test will be performed on the dominant leg, with eyes open and closed.
|
Baseline, 6 weeks
|
|
Quality of Life in Pregnancy Scale
Time Frame: Baseline, 6 weeks
|
The Quality of Life in Pregnancy Scale aims to assess the quality of life of women with a normal pregnancy and consists of 9 items.The total score of the scale ranges from 9 to 45, with lower scores indicating better quality of life.
|
Baseline, 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 26, 2025
Primary Completion (Actual)
November 12, 2025
Study Completion (Actual)
November 12, 2025
Study Registration Dates
First Submitted
February 19, 2025
First Submitted That Met QC Criteria
February 19, 2025
First Posted (Actual)
February 24, 2025
Study Record Updates
Last Update Posted (Actual)
December 10, 2025
Last Update Submitted That Met QC Criteria
December 9, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0196
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.